Table 2.
Clinical and biological features of 18 primary BC tissues.
| Cytological Classification | IHC Classification | Grade | Staging | PR (%) | HER2 | |
|---|---|---|---|---|---|---|
| PT#1 | C5 | Invasive carcinoma of no special type (NST) | G2 | pT1N0 | 70 | 3+ |
| PT#2 | Invasive carcinoma of no special type (NST) | G2 | pT1N0 | 70 | 0 | |
| PT#3 | Invasive carcinoma of no special type (NST) | G3 | pT2N2 | 60 | 1+ | |
| PT#4 | Invasive carcinoma of no special type (NST) | G3 | pT4bN0 | 0 | 3+ | |
| PT#5 | Invasive carcinoma of no special type (NST) | G2 | pT1N1a | 0.8 | 1+ | |
| PT#6 | Invasive carcinoma of no special type (NST) | G3 | pT4bN2a | 0.65 | 1+ | |
| PT#7 | Invasive carcinoma of no special type (NST) | G2 | pT2N1a | 0 | 0 | |
| PT#8 | Invasive apocrine carcinoma (IAC) | G3 | pT2N1a | 0 | 3+ | |
| PT#9 | Invasive mucinous carcinoma (IMC) | G2 | pT1cN0 | 0.7 | 0 | |
| PT#10 | Invasive Ductal Carcinoma (IDC) | G1 | pT2N0 | 0.03 | 0 | |
| PT#11 | Invasive carcinoma of no special type (NST) | G2 | pT2N1 | 0.9 | 1+ | |
| PT#12 | Invasive Ductal Carcinoma (IDC) | G3 | pT2N0 | 0.7 | 1+ | |
| PT#13 | Invasive Ductal Carcinoma (IDC) | G2 | pT1cN0 | 0 | 0 | |
| PT#14 | Invasive Ductal Carcinoma (IDC) | G3 | pT1bN1a | 0 | 2+ | |
| PT#15 | Invasive Ductal Carcinoma (IDC) | G2 | pT2N2 | <5 | 1+ | |
| PT#16 | Invasive Ductal Carcinoma (IDC) | G2 | pT1cN0 | 0.8 | 1+ | |
| PT#17 | Invasive Ductal Carcinoma (IDC) | G2 | pT1cN0 | 0.6 | 0 | |
| PT#18 | Invasive Ductal Carcinoma (IDC) | G2 | pT2N1M1 (bone) | 0.7 | 0 |